What Happened
- The United States Supreme Court ruled on 20 February 2026 (6-3 decision) that the International Emergency Economic Powers Act (IEEPA) of 1977 does not authorise the President to impose tariffs.
- The landmark ruling — in the case Learning Resources Inc. v. Trump — struck down sweeping tariffs that President Trump had imposed on imports from multiple countries under IEEPA, invoking national emergency powers.
- Chief Justice John Roberts authored the majority opinion, joined by Justices Sotomayor, Kagan, Gorsuch, Barrett, and Jackson; Justices Thomas, Kavanaugh, and Alito dissented.
- The ruling provided immediate relief for Indian exporters who had faced the prospect of paying 25% reciprocal tariffs on goods exported to the United States; these tariffs are now unconstitutional without legislative authorisation.
- The decision significantly curtails presidential unilateral trade power and may require the US administration to negotiate Congressional approval or bilateral agreements (like the India–US interim trade deal) to implement tariff changes.
Static Topic Bridges
The International Emergency Economic Powers Act (IEEPA) 1977 and Presidential Trade Powers
IEEPA was enacted by the US Congress in 1977 to clarify and restrict presidential emergency economic powers that had previously existed under the Trading with the Enemy Act (TWEA) of 1917. IEEPA authorises the President to "regulate" international transactions — including blocking, freezing, and licensing — when facing an "unusual and extraordinary threat" with a foreign source, after declaring a national emergency. The Trump administration interpreted this broadly to include imposing tariffs (revenue-raising duties) on imports, citing trade deficits as national emergencies. The Supreme Court majority rejected this interpretation, holding that "regulate" in IEEPA means control over transactions, not levying taxes on trade.
- IEEPA enacted: 28 December 1977, signed by President Jimmy Carter
- IEEPA empowers the President to: investigate, regulate, block, prohibit, or void transactions involving foreign interests
- Key distinction: tariffs are revenue measures (Article I, Section 8 of US Constitution gives Congress power to lay tariffs) — IEEPA does not explicitly delegate tariff authority
- No US president had invoked IEEPA to impose tariffs in its 50-year history before Trump's second term
- The Supreme Court applied the principle that Congress delegates tariff authority only through clear and specific statutes
Connection to this news: The Supreme Court's ruling confirmed that IEEPA cannot serve as a catch-all for presidential tariff imposition — a constitutional check on executive overreach that directly benefits countries like India that were subjected to these tariffs without Congressional authorisation.
US Constitutional Framework for Trade Policy: Separation of Powers
Under the US Constitution (Article I, Section 8), the power to "lay and collect taxes, duties, imposts and excises" and to "regulate commerce with foreign nations" belongs to the US Congress. Over time, Congress has delegated substantial trade authority to the executive branch through statutes like the Trade Expansion Act 1962 (Section 232 — national security tariffs), the Trade Act 1974 (Section 301 — unfair trade practices), and IEEPA 1977. The Supreme Court's February 2026 ruling is significant because it reasserts the primacy of Congressional authority over tariffs, limits the scope of IEEPA as an executive trade tool, and requires the executive to work within congressionally authorised frameworks.
- Article I, Section 8 of US Constitution: Congress has the power to levy tariffs and regulate foreign commerce
- Section 232 (Trade Expansion Act 1962): allows President to impose tariffs on national security grounds (steel/aluminium tariffs used under this provision)
- Section 301 (Trade Act 1974): allows President to respond to unfair trade practices — separate from IEEPA
- The US–India interim trade deal (reducing tariffs to 18%) remains valid because it modifies executive-imposed tariffs through bilateral agreement, not IEEPA imposition
- The IEEPA ruling does NOT affect Section 232 steel and aluminium tariffs (these were separately imposed)
Connection to this news: The IEEPA ruling reshapes the landscape of India–US trade negotiations: it eliminates the threat of arbitrary tariff escalation through emergency declarations, making bilateral trade agreements (like the India–US interim deal) more durable and institutionally grounded.
India's Export Sector and Vulnerability to US Tariff Policy
India's exports to the United States — its largest single-country trading partner — span pharmaceuticals (approximately $8–9 billion, particularly generics), engineering goods, gems and jewellery, chemicals, textiles, and IT services (approximately $70–80 billion including all services). The threat of 25% reciprocal tariffs under IEEPA had created uncertainty for Indian exporters, particularly in labour-intensive manufacturing sectors (apparel, leather, marine products). The sectors most exposed to US tariff risk are also the ones where India competes head-to-head with Vietnam, Bangladesh, and Cambodia — countries that maintained lower tariff exposure.
- India's total exports to the US (FY24): approximately $77 billion in goods and over $70 billion in services
- Pharmaceutical exports: approximately $8–9 billion (India supplies ~47% of US generic drug imports by volume)
- Labour-intensive goods most at risk from 25% tariffs: apparel, leather, marine products, carpets
- The IEEPA tariffs — had they been enforced — would have effectively raised the cost of Indian goods in the US by 25%, severely eroding price competitiveness
- With the IEEPA tariffs struck down AND the interim trade deal setting an 18% rate, Indian exporters gain both legal certainty and lower effective tariffs
Connection to this news: The Supreme Court ruling, combined with the India–US interim trade deal, creates a significantly improved operating environment for Indian exporters in the US market — potentially the most favourable in over a decade, representing a major shift in the bilateral trade dynamic.
Key Facts & Data
- Supreme Court ruling date: 20 February 2026
- Case name: Learning Resources Inc. v. Trump (607 U.S. ___ [2026])
- Decision: 6-3 (Roberts majority; Thomas, Kavanaugh, Alito dissenting)
- IEEPA enacted: 28 December 1977 by the US Congress
- Ruling: IEEPA does NOT authorise the President to impose tariffs
- Trump's IEEPA tariffs: 25% on most Canadian/Mexican goods, 10% on Chinese imports (drugs), minimum 10% on all imports
- India's threatened "reciprocal tariff" under IEEPA: approximately 25% (effective up to ~50% with Russia oil penalty)
- India–US interim deal tariff: 18% (now durable without IEEPA threat as backstop)
- India's pharmaceutical exports to US: approximately $8–9 billion (47% of US generic drug imports by volume)
- India's total goods exports to US: approximately $77 billion annually
- US Constitution Article I, Section 8: Congress holds power to levy tariffs and regulate foreign trade